Gene therapy for hereditary eye diseases: where are we?

Viet Tran, H.; Schorderet, D.F.; Kostic, C.; Munier, F.L.; Arsenijevic, Y.

Revue Medicale Suisse 5(186): 118-123

2009


ISSN/ISBN: 1660-9379
PMID: 19238930
Document Number: 12757
Recently, preliminary results of three clinical gene therapy trials for early onset retinitis pigmentosa--Leber congenital amaurosis--suggested that treating this degenerative retinal disease by gene transfection can be safe and efficient to restore a visual function. The definitive validation of this therapeutic approach depends on the long-term results. The forthcoming availability of gene therapy in ophthalmology prompts the implementation: of 1) recruitment, 2) phenotyping and genotyping of affected patients, 3) and creation of a hereditary retinopathy registry.

Document emailed within 1 workday
Secure & encrypted payments

Gene therapy for hereditary eye diseases: where are we?